Company Profile: Cann Group Ltd (ASX: CAN) is focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia and internationally. The group formed research and cultivation facilities in Melbourne and is striving to offer access to medicinal cannabis for Australian patients. They got Australia’s first medicinal cannabis research license in February 2017, and first medicinal cannabis cultivation license in March 2017. Aurora Cannabis Inc – one of Canada’s largest listed medicinal cannabis companies – has 22.9% shareholding in the group. The group has set the cannabis operation based on its experience in the agriculture sector in terms of development and commercialization.
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.
Click here for your FREE Report